NMDA receptors are expressed in oligodendrocytes and activated in ischaemia

Nature

Volumn 438, Issue 7071, 2005, Pages 1162-1166

  Káradóttir, Ragnhildur ^a   Cavelier, Pauline ^a   Bergersen, Linda H ^b   Attwell, David ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DISEASE CONTROL; DISEASES; MICROORGANISMS;

ISCHAEMIA; LEUKOMALACIA; NMDA RECEPTORS; OLIGODENDROCYTES;

PROTEINS;

MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR SUBUNIT 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR SUBUNIT 3; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

BIOLOGY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL MATURATION; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; EVOKED RESPONSE; INTRACELLULAR SPACE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; STEM CELL; WHITE MATTER;

ANIMALIA;

EID: 29244440745     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04302     Document Type: Article

References (29)

1. Volpe, J. J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 50, 553-562 (2001).
2. Stys, P. K. White matter injury mechanisms. Can. Mol. Med. 4, 113-130 (2004).
3. Matute, C. et al. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24, 224-230 (2001).
4. Dewar, D., Underhill, S. M. & Goldberg, M. P. Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab. 23, 263-274 (2003).
5. Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634 (1988).
6. Patneau, D. K., Wright, P. W., Winters, C., Mayer, M. L. & Gallo, V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12, 357-371 (1994).
7. Berger, T., Walz, W., Schnitzer, J. & Kettenmann, H. GABA- and glutamate-activated currents in glial cells of the mouse corpus callosum slice. J. Neurosci. Res. 31, 21-27 (1992).
8. Oka, A., Belliveau, M. J., Rosenberg, P. A. & Volpe, J. J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 13, 1441-1453 (1993).
9. Follett, P. L., Rosenberg, P. A., Volpe, J. J. & Jensen, F. E. NBQX attenuates excitotoxic injury in developing white matter. J. Neurosci. 20, 9235-9241 (2000).
10. Tekkök, S. B. & Goldberg, M. P. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J. Neurosci. 21, 4237-4248 (2001).
11. Agrawal, S. K. & Fehlings, M. G. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J. Neurosci. 17, 1055-1063 (1997).
12. Wrathall, J. R., Teng, Y. D. & Marriott, R. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp. Neurol. 145, 565-573 (1997).
13. Pitt, D., Werner, P. & Raine, C. S. Glutamate excitotoxicity in a model of multiple sclerosis. Nature Med. 6, 67-70 (2000).
14. Smith, T., Groom, A., Zhu, B. & Turski, L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nature Med. 6, 62-66 (2000).
15. Wang, C. et al. Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J. Cell Biol. 135, 1565-1581 (1996).
16. Ziak, D., Chvatal, A. & Sykova, E. Glutamate, kainate and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol. Res. 47, 365-375 (1998).
17. Schäbitz, W.-R., Li, F. & Fisher, M. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke 31, 1709-1714 (2000).
18. Wallström, E. et al. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J. Neurol. Sci. 137, 89-96 (1996).
19. Back, S. A. et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 21, 1302-1312 (2001).
20. Bergles, D. E., Roberts, J. D. B., Somogyi, P. & Jahr, C. E. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405, 187-191 (2000).
21. Kirson, E. D., Schirra, C., Konnerth, A. & Yaari, Y. Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells. J. Physiol. (Lond.) 521, 99-111 (1999).
22. 2+ block in NMDA receptor channels. J. Neurosci. 16, 3549-3558 (1996).
23. Sasaki, Y. F. et al. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J. Neurophysiol. 87, 2052-2063 (2002).
24. + entry. J. Neurosci. Res. 42, 579-593 (1995).
25. Allen, N. J., Káradóttir, R. & Attwell, D. A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J. Neurosci. 25, 848-859 (2005).
26. Yuan, X., Eisen, A. M., McBain, C. J. & Gallo, V. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125, 2901-2914 (1998).
27. Salter, M. G. & Fern, R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature doi:10.1038/nature04301 (this issue).
28. Berry, M., Hubbard, P. & Butt, A. M. Cytology and lineage of NG2-positive glia. J. Neurocytol. 31, 457-467 (2002).
29. Chittajulu, R., Aguirre, A. & Gallo, V. NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J. Physiol. (Lond.) 561, 109-122 (2004).